PEDIATRICS Vol. 61 No. 1 January 1978, pp. 83-90
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orlowski, J. P.
Right arrow Articles by Dyment, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orlowski, J. P.
Right arrow Articles by Dyment, P. G.

Wegener's Granulomatosis in the Pediatric Age Group

James P. Orlowski M.D.1, John D. Clough M.D.1, and Paul G. Dyment M.D.1

1 Department of Pediatric and Adolescent Medicine and the Department of Rheumatic Disease, The Cleveland Clinic Foundation, Cleveland

Six cases of Wegener's granulomatosis (WG) occurring in patients younger than 21 years are described. Only 11 other cases in the pediatric age group have been reported, and all 17 of these patients had the onset of the disease during the second decade of life. Wegener's granulomatosis is a systemic disease characterized by a clinical triad of paranasal sinus and nasal mucosa involvement, pulmonary infiltration and cavitation, and renal disease with hematuria. The most common presenting symptoms are malaise and fever, sinusitis, epistaxis, and hematuria. Most patients have roentgenographic evidence of pulmonary and sinus disease and laboratory evidence of renal involvement on initial evaluation. The prognosis of WG was formerly dismal; more than 90% of patients died in less than two years, but with recent therapeutic regimens, more than 50% of these patients are surviving. The treatment we recommend consists of nitrogen mustard with adrenocorticotropic hormone or prednisone for the induction of remission, followed by cyclophosphamide and prednisone as maintenance drugs. This regimen has proved effective in inducing a remission in four of four patients.

Submitted on August 4, 1977
Accepted on September 29, 1977




This article has been cited by other articles:


Home page
 LupusHome page
M J Dillon
Childhood vasculitis
Lupus, May 1, 1998; 7(4): 259 - 265.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
G. L. Freed
Wegener's Granulomatosis Presenting as Fever of Unknown Origin
Clinical Pediatrics, March 1, 1994; 33(3): 162 - 165.
[PDF]

Home page
 NEJMHome page
N. D. Rosenblum and R. B. Colvin
Case 16-1993- A 13-Year-Old Girl with Gross Hematuria Four Years after a Diagnosis of Idiopathic Pulmonary Hemosiderosis
N. Engl. J. Med., April 22, 1993; 328(16): 1183 - 1190.
[Full Text]